Radical prostatectomy as treatment for prostate-specific antigen-detected stage Tic prostate cancer

World Journal of Urology

Volumn 15, Issue 6, 1997, Pages 373-377

  Charles, R ^a   Patrick, Pound ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; PROSTATECTOMY; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUMOR RECURRENCE;

ACTUARIAL ANALYSIS; ADULT; AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0031309553     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf01300186     Document Type: Article

References (15)

1. Catalona WJ, Smith DJ (1994) Five-year tumor recurrence rates after anatomic radical retropubic prostatectomy for prostate cancer. J Urol 152: 1837-1842
2. Catalona WJ, Smith DS, Ratliff TL, Basler JW(1993) Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270: 948-954
3. Epstein JI, Walsh PC, Brendler CB(1994) Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages Tla and Tib) and on needle biopsy (stage Tic). J Urol 152: 1721-1729
4. Epstein JI, Walsh PC, Carmichael M. Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tic) prostate cancer. JAMA 271: 368374
5. Humphrey PA, Keetch DW, Smith DS, Shepherd DL, Catalona WJ (1996) Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. J Urol 155: 816-820
6. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-463
7. Lerner SE, Seay TM, Blute ML, Bergstralh D, Zincke H (1996) Prostate specific antigen detected prostate cancer (clinical stage Tic): an interim analysis. J Urol 155: 821-826
8. Matthews GJ, Fracchia JA (1995) PSA-detected prostate cancer: contrasts with palpable disease. J Surg Oncol 59: 28-30
9. Oesterling JE, Suman VJ, Zincke H, Bostwick DG (1993) PSAdetected (clinical stage Tic or BO) prostate cancer. Urol Clin North Am 20: 687-693
10. Partin AW, Oesterling JE(1994) The clinical usefulness of prostate specific antigen: update 1994. J Urol 152: 1358-1368
11. Partin AW, Pound CR, Clemens JQ, Epstein JI. Walsh PC (1993) Serum PSA after anatomic radical prostatectomy: the Johns Hopkins experience after 10 years. Urol Clin North Am 20: 713-725
12. Pound CR, Partin AW. Epstein JI. Walsh PQ1997) PSA following anatomic radical retropubic prostatectomy: patterns of recurrence and cancer control. Urol Clin North Am 24: 395-406
13. Schröder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK Pavone-Macaluso M (1992) The TNM classification of prostate cancer. Prostate Suppl. 4: 129-138
14. Smith DS, Catalona WJ(1994) The nature of prostate canceldetected through prostate specific antigen based screening. J Urol 152: 1732-1736
15. Trapasso JG, DeKernion JB, Smith RB, Dorey F (1994) The incidence and significance of detectable levels of serum PSA after radical prostatectomy. J Urol 152: 1821-1825